Brexpiprazole in Treatment of Children and Adolescents With Irritability Associated With Autism Spectrum Disorder
Clinical trial NCT04174365 · COMPLETED
Trial details
- NCT number
- NCT04174365
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-30
- Primary completion
- 2022-08-08
- Enrollment
- 119
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.